Last updated: 2026-09-28 20:07:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.96, with a market capitalization of $953.28K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $16.68. This page covers its latest market performance, valuation, price trends and company information.
$953.28K | |
$0.94 | |
$200,000.00 | |
$0.80 | |
$0.92 | |
221.25K | |
5.71M | |
-- | |
$16.68 | |
$0.80 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) is trading at $0.96 in after-hours trading as of 2026-09-28 20:05:00, up 3.98% ($0.04) from the regular-session close of $0.92.
After-hours trading shows how investors are pricing BJDX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $0.85 to $0.96, representing a gain of 13.02% ($0.11).
The stock traded between $0.81 and $1.03 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 998.76 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.0%
BJDX is currently trading at $0.96, placing it 1.0% of the way from its 52-week low of $0.80 to its 52-week high of $16.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.